GUJARAT THEMIS BIOSYN
|
|
BOM : 506879     NSE : GUJTHEMIS     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jul 01,2022 |
Price(EOD): ₹ 432.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 627.05 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
GUJARAT THEMIS BIOSYN | 2.8% | 1% | 36.3% |
SUN PHARMACEUTICAL INDUSTRIES | -1.1% | -3.8% | 22.7% |
DIVIS LABORATORIES | -1.1% | 3.1% | -14.6% |
DR REDDYS LABORATORIES | 1.6% | 1.2% | -17.2% |
CIPLA | 1.9% | -3.8% | -6.5% |
GLAND PHARMA | -0.1% | -6.5% | -20.6% |
PIRAMAL ENTERPRISES | 0.3% | -8% | -31.3% |
CADILA HEALTHCARE | 2.3% | -0.8% | -44.3% |
TORRENT PHARMACEUTICALS | 1.9% | 3.6% | -2.1% |
FUNDAMENTAL ANALYSIS OF GUJARAT THEMIS BIOSYN
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF GUJARAT THEMIS BIOSYN
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
20.82
P/E Calculated based on EPS of 20.77
[ Mar2021 - Standalone Results ] 8.98
P/B Calculated based on Book Value of 48.14
[ Mar2021 - Standalone Results ] 5.46
P/S Calculated based on Revenues of 114.854 Cr
[ TTM - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
194% 174% 177% |
SHARE PRICE MOMENTUM OF GUJARAT THEMIS BIOSYN
GUJARAT THEMIS BIOSYN vs SENSEX
DEBT OF GUJARAT THEMIS BIOSYN
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2021 2020 2019 Avg_3yrs |
0.04 0.19 0.32 0.18 |
- - - - |
[Last Annual Data : Mar2021]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF GUJARAT THEMIS BIOSYN
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF GUJARAT THEMIS BIOSYN
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
54.61% 33.52% 44.57% 37.45% |
23.46% 57.53% 70.45% 69.05% |
QtrlyTrend |
8 | |
Latest Qtr: Mar2022 | ||
Quarterly Result Analysis → |
GUJARAT THEMIS BIOSYN related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 1.2% | -6.5% | -1.2% |
S&P BSE MIDSMALLCAP | 0.7% | -6% | -2.3% |
S&P BSE ALLCAP | 0.6% | -4.9% | -0.8% |
S&P BSE HEALTHCARE | 0.3% | -2.1% | -14.3% |
You may also like the below Video Courses
FAQ about GUJARAT THEMIS BIOSYN
Is GUJARAT THEMIS BIOSYN good for long term investment?
As on Jul 01,2022, the Fundamentals of GUJARAT THEMIS BIOSYN look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of GUJARAT THEMIS BIOSYN . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is GUJARAT THEMIS BIOSYN UnderValued or OverValued?
As on Jul 01,2022, GUJARAT THEMIS BIOSYN is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of GUJARAT THEMIS BIOSYN ?
As on Jul 01,2022, the Intrinsic Value of GUJARAT THEMIS BIOSYN is Rs. 155.85 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 147.16
Fair Value [Median EV / Sales Model] : Rs. 157.88
Fair Value [Median Price / Sales Model] : Rs. 155.85
Median Fair Value of GUJARAT THEMIS BIOSYN : Rs. 155.85
Is GUJARAT THEMIS BIOSYN trading at a Premium or Discount?
As on Jul 01,2022, GUJARAT THEMIS BIOSYN is trading at a Premium of 177% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
